Roche extends $4.3 billion offer for Spark Therapeutics as regulators review
PHILADELPHIA - Roche, the Switzerland-based drugmaker, says it has extended its $4.3 billion offer to buy all shares of Philadelphia-based Spark Therapeutics Inc. from investors pa…
